Stay updated on NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.

Latest updates to the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing the previous v3.2.0. This is a minor version update with no changes to study details or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedNotice about government funding status was removed from the page. The removed notice previously warned that information may not be up to date and directed users to cc.nih.gov and opm.gov for status updates.SummaryDifference0.4%

- Check42 days agoChange DetectedResults for the study were posted, including progression-free survival, objective response rate, and safety data. The study record dates were updated to reflect the availability of results.SummaryDifference0.4%

- Check57 days agoChange DetectedAdditions substantially update the study description with precise dosing, duration, endpoints, and reporting dates; deletions remove the older, shorter phrasing. Overall, the page content has been significantly expanded and clarified.SummaryDifference8%

- Check71 days agoChange DetectedAdditions introduce a government funding notice and confirm the NIH Clinical Center is open, plus a v3.2.0 revision; deletions remove v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.